A Case Report on Post-haemodialysis Pyrexia Caused due to a Rare Species of Trichosporon

Hypertension is a global health threat, which, in coexistence with chronic kidney disease, increases the associated health risks. Most of the vulnerable patients receive prophylactic therapeutic intervention for fungal infections, though, in a few instances, there is a delay in symptomatic presentation. The patients with hypertension and chronic kidney disease receiving haemodialysis should be monitored strictly for the same. This is a case of a 41-year-old male infected with Trichosporon infection with a positive history of hypertension and chronic kidney disease, receiving haemodialysis treatment. The patient was timely confirmed to have the diagnosis and successfully managed with the systemic antifungal drug Itraconazole {100 mg (BD) for 14 days} and Fluoroquinolones {500 mg (OD) for seven days}. A follow-up at one month showed the patient with laboratory markers within normal limits.